Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Reddit to offer IPO shares to biggest users - report

(Sharecast News) - Social media firm Reddit is reportedly planning to offer shares in its initial public offering to 75,000 of its biggest users when it hits the market next month. The Wall Street Journal cited people familiar with the matter as saying that the move is aimed at building loyalty. However, it could backfire if the stock falls in its debut.

Reddit CEO Steve Huffman said at The WSJ 's Tech Live conference in 2021 that he wanted to make any offering more accessible to individuals.

"I want our users to be shareholders, and I want our shareholders to be users," he said at the time.

It was understood that users will have the opportunity to buy the stock at its issue price - an unusual move that is normally preserved for big institutional investors. That investor base is deemed safer as it generally holds the stock for a longer period than retail investors, who are expected to be more likely to sell on weakness.

Reddit filed confidentially for an IPO in late 2021 and is expected to make its documents public later this month and seek to list on the New York Stock Exchange in March. The company achieved a valuation of $10bn in a fundraising round in August 2021, but valuations have shifted since then.

Share this article

Related Sharecast Articles

UBS to book $900m provision over Greensill supply financing funds
(Sharecast News) - Swiss banking giant UBS announced on Monday that it expected to book a provision of about $900m related to Credit Suisse's funds, tied to the collapsed supply chain financing firm Greensill Capital.
Citi downgrades European equities to 'neutral'
(Sharecast News) - Citi downgraded its stance on European equities on Monday to 'neutral' from 'overweight' as it said near-term risks have increased, with markets narrowing and political uncertainty taking centre stage.
Hutchmed publishes positive sovleplenib trial results
(Sharecast News) - Hutchmed China announced the publication of positive results from its phase three 'ESLIM-01' trial of sovleplenib in the Lancet Haematology.
Somero trading in line with expectations
(Sharecast News) - Somero Enterprises said in an update on Monday that trading for the first five months of 2024 was consistent with expectations.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.